That's awesome to know dts bro!!! So in other words we have a real possibility of at least 3 and quite possibly 4 new ANDA approvals finally arriving at various points over the next 12 months(1 per Q perhaps)!!!
And that's on top of the coming FocalinXR ANDA approvals of the 5, 10 & 20mg strengths b4 year end this year...PLUS the BIGGIE catalysts surrounding their Rexista NDA as follows>>>
-Rexista bioequivalence submission sometime in December of this year! -Rexista partnership announcement! -Official Rexista NDA submission to the FDA early next year! -FDA approval of Rexista sometime next year!